McCarthy Stone Plc (LON:MCS) “Buy” Rating Reconfirmed by Peel Hunt; With GBX 180.00 Target; Eventide Asset Management Upped Uniqure Nv (QURE) Position By $9.36 Million

uniQure N.V. (NASDAQ:QURE) Logo

Eventide Asset Management Llc increased Uniqure Nv (QURE) stake by 92.31% reported in 2019Q3 SEC filing. Eventide Asset Management Llc acquired 240,000 shares as Uniqure Nv (QURE)’s stock rose 44.50%. The Eventide Asset Management Llc holds 500,000 shares with $19.68 million value, up from 260,000 last quarter. Uniqure Nv now has $3.03B valuation. The stock increased 0.36% or $0.25 during the last trading session, reaching $69.56. About 455,196 shares traded. uniQure N.V. (NASDAQ:QURE) has risen 114.80% since January 16, 2019 and is uptrending. It has outperformed by 114.80% the S&P500. Some Historical QURE News: 21/05/2018 – UNIQURE NV – NEW DATA FURTHER DEMONSTRATING FAVORABLE IMMUNOGENICITY PROFILE OF AAV5; 07/05/2018 – UniQure Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shrs; 01/05/2018 – uniQure Announces Proposed Public Offering; 30/04/2018 – UniQure 1Q EPS 59c; 14/03/2018 – UniQure Expects Cash and Cash Equivalents Will Be Sufficient to Fund Ops Into Early 2020; 30/04/2018 – UniQure IND Filing for AMT-130 in Huntington’s Disease Expected in 2H of 2018; 28/03/2018 – uniQure NV Field Trip Scheduled By Chardan for Apr. 4-5; 14/03/2018 – UniQure 2017 Loss $79.3M; 29/05/2018 – uniQure Announces the Issuance of New Patents Providing Broad Protection of the Padua Variant of Factor IX in Gene Therapy; 18/05/2018 – uniQure Presents Preclinical Data Demonstrating Advances in the Distribution of Gene Therapy

Stock research analysts at Peel Hunt have GBX 180.00 price target on McCarthy Stone Plc (LON:MCS). Peel Hunt’s price target indicates a potential upside of 27.34% from the company’s stock close price. The rating was disclosed in an analyst report on 13 January.

Another recent and important McCarthy & Stone plc (LON:MCS) news was published by Finance.Yahoo.com which published an article titled: “Shareholders Should Look Hard At McCarthy & Stone plc’s (LON:MCS) 7.0%Return On Capital – Yahoo Finance” on January 03, 2020.

The stock increased 0.56% or GBX 0.8 during the last trading session, reaching GBX 143.7. About 66,507 shares traded. McCarthy & Stone plc (LON:MCS) has 0.00% since January 16, 2019 and is . It has by 0.00% the S&P500. Some Historical MCS News: 11/04/2018 – The Marcus Corporation to Webcast May 8, 2018 Annual Shareholders’ Meeting; 26/04/2018 – Marcus Corp 1Q EPS 35c; 22/04/2018 – DJ Marcus Corporation, Inst Holders, 1Q 2018 (MCS); 12/03/2018 – Marcus Corp Rises for 8 Days; Tied for Longest Rally; 26/04/2018 – Marcus Corp 1Q Rev $168.2M; 15/05/2018 – Nationally Recognized Firms Selected to Design Milwaukee’s First Arts-Focused Hotel; 15/05/2018 – Nationally Recognized Firms Selected to Design Milwaukee’s First Arts-Focused Hotel; 11/04/2018 – The Marcus Corporation to Webcast May 8, 2018 Annual Shareholders’ Meeting; 26/04/2018 – MARCUS CORP 1Q REV. $168.2M, EST. $158.3M; 07/04/2018 – jenny strasburg: Breaking on @DowJones Deutsche Bank Investment-Banking Executive Marcus Schenck Has Discussed Leaving. More to

McCarthy & Stone plc, together with its subsidiaries, operates as a retirement house builder in the United Kingdom. The company has market cap of 772.19 million GBP. The firm builds, sells, and manages retirement developments. It has a 18.91 P/E ratio. It offers retirement living developments that provide owner-occupied apartments for those aged 60 and over; assisted living developments, which are designed for clients aged 70 and offers a retirement apartment with management services, domestic assistance, personal care, and additional support; and Ortus Homes for clients aged 55 and over.

Investors sentiment decreased to 1.12 in Q3 2019. Its down 0.30, from 1.42 in 2019Q2. It worsened, as 18 investors sold McCarthy & Stone plc shares while 51 reduced holdings. 20 funds opened positions while 57 raised stakes. 19.99 million shares or 3.92% more from 19.24 million shares in 2019Q2 were reported. Manufacturers Life Ins Com The has 14,233 shares. Bnp Paribas Arbitrage Sa, New York-based fund reported 3,318 shares. Ameriprise Inc has 134,305 shares. North Carolina-based Fincl Bank Of America Corp De has invested 0% in McCarthy & Stone plc (LON:MCS). Ghp Investment Advsrs stated it has 49,109 shares. Art Advsr Limited Liability Co has invested 0.02% in McCarthy & Stone plc (LON:MCS). Deutsche National Bank Ag has 0% invested in McCarthy & Stone plc (LON:MCS). Morgan Stanley invested in 89,608 shares. Gamco Investors Incorporated Et Al has 0.26% invested in McCarthy & Stone plc (LON:MCS). Blackrock invested in 3.51 million shares or 0.01% of the stock. State Board Of Administration Of Florida Retirement System holds 20,314 shares or 0% of its portfolio. Moreover, Parametric Port Assocs Ltd Liability has 0% invested in McCarthy & Stone plc (LON:MCS) for 91,056 shares. Nuveen Asset Mgmt Lc, a Illinois-based fund reported 181,702 shares. Savings Bank Of Montreal Can, a Ontario – Canada-based fund reported 10,949 shares. Clearbridge Invests Lc accumulated 1,200 shares.

Among 6 analysts covering McCarthy Stone Plc (LON:MCS), 3 have Buy rating, 2 Sell and 1 Hold. Therefore 50% are positive. McCarthy Stone Plc has GBX 180 highest and GBX 125 lowest target. GBX 151.50’s average target is 5.43% above currents GBX 143.7 stock price. McCarthy Stone Plc had 19 analyst reports since July 23, 2019 according to SRatingsIntel. The firm has “Sell” rating by UBS given on Wednesday, December 4. The firm has “Buy” rating by Jefferies given on Thursday, November 7. The firm earned “Hold” rating on Thursday, January 9 by Berenberg. The rating was downgraded by Canaccord Genuity to “Sell” on Tuesday, January 7. The firm has “Buy” rating given on Monday, January 13 by Peel Hunt. Deutsche Bank upgraded the stock to “Buy” rating in Tuesday, January 14 report. The firm has “Buy” rating given on Friday, September 27 by Jefferies. The company was maintained on Friday, October 25 by UBS.

Analysts await McCarthy & Stone plc (LON:MCS) to report earnings on February, 20. They expect $0.37 EPS, down 9.76% or $0.04 from last year’s $0.41 per share. MCS’s profit will be $1.99M for 97.09 P/E if the $0.37 EPS becomes a reality. After $0.50 actual EPS reported by McCarthy & Stone plc for the previous quarter, Wall Street now forecasts -26.00% negative EPS growth.

Among 7 analysts covering uniQure (NASDAQ:QURE), 7 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. uniQure has $9800 highest and $6700 lowest target. $81.29’s average target is 16.86% above currents $69.56 stock price. uniQure had 15 analyst reports since July 30, 2019 according to SRatingsIntel. On Tuesday, December 10 the stock rating was maintained by Mizuho with “Buy”. The rating was maintained by H.C. Wainwright with “Buy” on Monday, October 14. The stock of uniQure N.V. (NASDAQ:QURE) has “Buy” rating given on Monday, October 28 by Robert W. Baird.

More notable recent uniQure N.V. (NASDAQ:QURE) news were published by: Finance.Yahoo.com which released: “uniQure (NASDAQ:QURE) Shareholders Have Enjoyed A Magnificent 1077% Share Price Gain – Yahoo Finance” on January 07, 2020, also Nasdaq.com with their article: “Interesting QURE Put And Call Options For February 21st – Nasdaq” published on January 08, 2020, Nasdaq.com published: “3 Stocks That Could Be the Next Biotech Buyouts – Nasdaq” on December 23, 2019. More interesting news about uniQure N.V. (NASDAQ:QURE) were released by: Streetinsider.com and their article: “SunTrust Assumes uniQure BV (QURE) at Buy – StreetInsider.com” published on December 20, 2019 as well as Bizjournals.com‘s news article titled: “Cambridge startup raises $110M for re-doseable gene therapies – New York Business Journal” with publication date: January 10, 2020.

Eventide Asset Management Llc decreased Taiwan Semiconductor Mfg Ltd (NYSE:TSM) stake by 16,700 shares to 4,800 valued at $223,000 in 2019Q3. It also reduced Magenta Therapeutics Inc stake by 539,807 shares and now owns 2.96 million shares. Sutro Biopharma Inc was reduced too.

uniQure N.V. (NASDAQ:QURE) Ratings Chart